Overview

Detailed Summary

Jupiter Life Line Hospitals Limited is a multi-speciality healthcare provider based in Western India, with facilities in Thane, Pune, and Indore, and a new hospital in Dombivli. Their core business involves tertiary and quaternary medical services across over 30 specialties.
The company successfully completed a significant capex project, a 500-bed hospital in Dombivli, ahead of schedule, exemplifying efficient project execution strategies under budget constraints.
Despite steady operating momentum and comprehensive healthcare services, Jupiter's financials reflect a decrease in PAT for Q3 FY26, influenced by new labor code changes and increased depreciation from new developments.
Jupiter Life Line achieves competitive occupancy and ARPOB rates, leveraging strategic location choices in high-demand micro markets with relatively low supply of high-end tertiary care services.
Jupiter continues to adopt a growth strategy focusing on capacity expansion, enhancing patient care infrastructure, and operational efficiency in line with their 'patient first' philosophy.

Sector: Healthcare Services
Industry: Hospital
Market Cap: 8,575 Cr
Volatility: Low Risk
P/E Ratio: 44.2
Industry P/E: 59.0
PEG Ratio: 1.5
P/B Ratio: 5.7
52W High: 1,618.15
52W Low: 1,152.05

Sales CAGR

1Y: 17.52%
3Y: 17.27%
5Y: 18.02%
10Y: —

Profit CAGR

1Y: 9.56%
3Y: 29.69%
5Y: 44.19%
10Y: —

ROE

TTM: 12.56%
3Y: 14.17%
5Y: 14.67%
10Y: —

ROCE

TTM: 13.77%
3Y: 18.21%
5Y: 17.49%
10Y: —

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Healthcare Healthcare Healthcare Services Hospital

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
RAINBOW		1320.00	13,472 Cr	48.40	8.17	0.26	16.89	16.88	10.15
PARKHOSPS		293.60	12,628 Cr	49.79	6.28	0.00	12.77	17.33	9.55
HCG		635.90	9,464 Cr	687.76	7.10	0.00	2.90	7.81	0.58
JLHL		1334.85	8,763 Cr	45.17	5.68	0.07	12.56	13.77	8.15
YATHARTH		840.00	8,081 Cr	45.88	4.54	0.00	9.85	11.09	7.50
KOVAI		5748.75	6,289 Cr	25.73	4.77	0.26	18.53	20.76	11.83
ARTEMISMED		258.95	4,095 Cr	38.66	4.73	0.17	11.09	13.95	7.26
Median: 7 Co.	—	840.00	8,763 Cr	45.88	5.68	0.07	12.56	13.95	8.15

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	273	290	287	323	321	327	348	394	365	388
Expenses	211	228	223	248	246	248	270	301	282	299
Operating Profit	62	62	64	75	75	78	78	92	83	89
OPM %	22.69	21.44	22.24	23.25	23.39	23.95	22.47	23.44	22.83	22.99
Other Income	7.91	11	8.37	9.44	8.30	7.03	13	11	2.73	11
Interest	1.03	0.93	1.08	1.12	2.78	5.57	8.26	7.84	7.55	9.01
Depreciation	11	10	11	14	14	18	21	21	22	23
Profit Before Tax	58	62	60	69	67	62	62	74	57	68
Tax %	24.83	27.22	25.84	25.25	21.09	27.73	28.70	22.57	25.32	25.59
Net Profit	44	45	45	52	53	45	44	57	43	50
EPS in Rs	6.56	6.49	6.80	7.86	8.01	6.84	6.69	8.75	6.49	7.66

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	463	486	733	893	1,070	1,262	1,318
Expenses	380	419	580	691	831	965	1,011
Operating Profit	83	67	153	201	238	297	306
OPM %	17.84	13.81	20.92	22.56	22.27	23.51	23.25
Other Income	1.89	4.11	3.82	8.22	26	29	38
Interest	26	39	44	42	26	11	18
Depreciation	26	31	36	39	42	57	67
Profit Before Tax	33	1.56	77	129	195	258	259
Tax %	9.90	247.72	33.70	43.36	9.62	24.91	25.60
Net Profit	30	-2.30	51	73	177	194	193
EPS in Rs	—	—	—	12.94	28.65	29.51	29.59
Dividend Payout %	0.00	0.00	0.00	0.00	3.49	3.39	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	51	51	51	57	66	66
Reserves	186	188	243	309	1,103	1,291
Borrowings	272	426	495	469	0.00	393
Other Liabilities	94	124	120	151	112	156
Total Liabilities	603	789	909	986	1,281	1,905
Fixed Assets	435	630	684	720	718	977
CWIP	11	26	27	29	74	185
Investments	2.32	7.36	2.88	1.55	17	114
Other Assets	156	126	195	235	473	628
Total Assets	603	789	909	986	1,281	1,905

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	74	123	137	117	115	253
Cash from Investing Activity	-43	-295	-84	-104	-76	-209
Cash from Financing Activity	-32	184	32	18	128	301
Net Cash Flow	-0.92	12	85	31	167	345

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%
FIIs	4.62%	3.97%	4.17%	6.06%	8.84%	10.04%	10.03%	9.77%	9.06%	8.48%	8.48%
DIIs	16.14%	17.35%	17.58%	17.27%	16.87%	15.74%	15.63%	15.82%	16.95%	17.43%	17.01%
Public	38.32%	37.77%	37.34%	35.76%	33.37%	33.30%	33.42%	33.50%	33.08%	33.17%	33.60%
Total Shareholders	54,782	39,348	35,107	35,797	34,081	33,914	33,956	34,192	34,361	33,620	32,985

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan